Validic offers a remote monitoring platform, Validic Impact, and a health data platform, Validic Inform, that enable the seamless capture, access, and integration of personal health data into health incentive and condition management programs.
Validic Inform is a data connectivity platform that powers the access, standardization, and integration of personal health data from 500+ health technologies – such as wearables, health apps, home-use medical devices, and more. As healthcare’s first streaming platform providing access to personal health data, Validic Inform provides a single connection point for ingesting data derived from hundreds of connected (and non-connected) data sources – in near-real time.
The platform enables organizations to power a true bring-your-own-device (BYOD) strategy, meaning companies can integrate activity, sleep, vitals or biometric data regardless of device manufacturer or connectivity type [e.g. API, OCR, Bluetooth, SDK].
Validic Impact is a remote monitoring platform that enables seamless management of remote patient monitoring (RPM) programs within the hospital's existing clinical systems. Validic Impact helps healthcare providers manage treatment programs for multiple disease states – such as diabetes, COPD, hypertension, and heart failure.
Distinct from other RPM offerings on the market, Validic Impact: Integrated, as the name suggests, integrates goals, content, dashboards, alerting, and other virtual care functionality directly into the electronic health record – the core clinical system.
Recently, Validic launched a standalone version of its RPM solution with front-end visualizations, a patient application, analytics and support dashboards – specifically for providers that need to launch quickly in response to the pandemic and can't take time to integrate systems. Validic Impact: Rapid Deployment can be launched in days and offers a price-point provider practices and publicly-funded programs can support. Validic created an easily deployed module for tracking COVID-19 specifically.